KORU Medical Systems (KRMD) Stock Analysis

What KORU Medical Systems does

KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the firm's corporate headquarters are situated in Chester, New York.

Key metrics

ETFs linked to KRMD

Broad-market and Healthcare sector ETFs an investor holding KORU Medical Systems is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how KRMD fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for KORU Medical Systems?

KORU Medical Systems trades under the ticker KRMD on NASDAQ.

Which exchange is KRMD listed on?

KRMD is listed on NASDAQ.

What sector does KORU Medical Systems operate in?

KORU Medical Systems is classified in the Healthcare sector (Medical - Instruments & Supplies industry).

How can PortView help analyze KRMD in a portfolio?

PortView shows KRMD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.